(IBDT) iShares iBonds Dec 2028 - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US46435U5157
IBDT: Corporate Bonds, Investment-Grade, Fixed Income, Target Maturity, 2028
The iShares iBonds Dec2028 Term Corporate ETF (IBDT) is a target maturity ETF that tracks an underlying index of investment-grade corporate bonds with a maturity date in December 2028. The funds investment strategy is to replicate the performance of the underlying index by investing at least 80% of its assets in the component securities and at least 90% in fixed income securities of similar types.
The underlying index comprises U.S. dollar-denominated, investment-grade bonds issued by U.S. and non-U.S. corporate issuers with a minimum outstanding face value of $300 million at the time of inclusion. This suggests that the fund will hold a diversified portfolio of high-quality corporate bonds with a relatively low credit risk.
From a technical analysis perspective, the funds price is currently trading above its 20-day, 50-day, and 200-day simple moving averages (SMA20, SMA50, and SMA200), indicating a positive trend. The Average True Range (ATR) is relatively low at 0.10, suggesting that the funds price is experiencing low volatility. Based on the current technical indicators, it is likely that the funds price will continue to trend upwards, potentially reaching a new 52-week high.
Considering the funds fundamental data, the Assets Under Management (AUM) stand at $2871.86 million, indicating a sizable and liquid ETF. As the fund approaches its maturity date in December 2028, it is likely that the credit risk will decrease, and the funds price will be influenced more by changes in interest rates. Given the current interest rate environment and the funds characteristics, a potential forecast is that the funds price will continue to rise, potentially reaching $26.00 by the end of 2024, driven by a combination of carry and potential price appreciation as the funds credit risk decreases.
To validate this forecast, it is essential to continue monitoring the funds technical and fundamental data, including changes in interest rates, credit spreads, and the overall market environment. By doing so, it is possible to refine the forecast and make adjustments as necessary to optimize investment decisions.
Additional Sources for IBDT ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
IBDT ETF Overview
Market Cap in USD | 2,865m |
Category | Target Maturity |
TER | 0.10% |
IPO / Inception | 2018-09-18 |
IBDT ETF Ratings
Growth Rating | 16.7 |
Fundamental | - |
Dividend Rating | 72.0 |
Rel. Strength | -5.87 |
Analysts | - |
Fair Price Momentum | 24.94 USD |
Fair Price DCF | - |
IBDT Dividends
Dividend Yield 12m | 4.65% |
Yield on Cost 5y | 4.82% |
Annual Growth 5y | 7.06% |
Payout Consistency | 95.6% |
Payout Ratio | % |
IBDT Growth Ratios
Growth Correlation 3m | 90.1% |
Growth Correlation 12m | 87.1% |
Growth Correlation 5y | -12.9% |
CAGR 5y | 1.06% |
CAGR/Max DD 5y | 0.06 |
Sharpe Ratio 12m | 1.96 |
Alpha | 3.00 |
Beta | 0.006 |
Volatility | 2.74% |
Current Volume | 478k |
Average Volume 20d | 476.8k |
As of June 29, 2025, the stock is trading at USD 25.40 with a total of 478,046 shares traded.
Over the past week, the price has changed by +0.51%, over one month by +1.02%, over three months by +2.00% and over the past year by +7.26%.
Neither. Based on ValueRay´s Analyses, iShares iBonds Dec 2028 is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 16.67 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of IBDT is around 24.94 USD . This means that IBDT is currently overvalued and has a potential downside of -1.81%.
iShares iBonds Dec 2028 has no consensus analysts rating.
According to our own proprietary Forecast Model, IBDT iShares iBonds Dec 2028 will be worth about 26.9 in June 2026. The stock is currently trading at 25.40. This means that the stock has a potential upside of +6.06%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 26.9 | 6.1% |